Phio Pharmaceuticals, confirmation slips
Phio Pharmaceuticals stock drops 4.2%: confirmation week flags an exit
Our view last week
After sixteen weeks under a Sell signal, Phio Pharmaceuticals turns: the week closes up 8.3%, with a 9% bounce off the daily 20-day moving average that opens a fresh Buy signal. Phio Pharmaceuticals stock still faces a real wall overhead — the 7-day high has already rejected the price four times — and the trigger only fires once that level breaks. Healthcare stocks are running hot right now, and that backs the turnaround case.
This week's summary
Last week's bounce on Phio Pharmaceuticals has already reversed: the first confirmation week of the buy signal closes down 4.2%, with sellers back in charge of the latest bar after buyer dominance collapsed. On the daily chart, though, the stock still bounced 3% off its 20-day moving average, and the wall in the 1.24 area remains the level to break. Technical analysis of Phio Pharmaceuticals stock points to short-term caution.
IQS Phase
49
ordinary
Signal Strength
74
high · wide & volatile
Sizing
FULL
Ranking
#65 / 175
US stocks in progress
Trade P&L %
-4.24%
from signal to date, no stop loss
Rank position
ranks 65th among the 175 Longs already running for US stocks in our ranking, with a signal strength of 74 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly -1.98% · monthly +2.96%
PHIO belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content